Recognition and Treatment of Depression in Parkinson's Disease

Depression in Parkinson's disease (PD) is common, but little is known about its recognition and treatment. The authors report the antidepressant experience (N = 100) and outcome of depression assessment (n = 77) of a convenience sample of patients at a PD center. Subjects were assessed with a psychiatric and neurological battery, and information was gathered on depression treatment. One third (34%) of subjects met criteria for a depressive disorder, and two thirds (65%) of them were not currently receiving antidepressant treatment. Approximately one quarter (23%) of subjects were taking an antidepressant, but almost half (47%) of them still met criteria for a depressive disorder. Few antidepressant users with persistent depression had received either antidepressant treatment at dosages within the highest recommended range (11%) or more than 1 antidepressant trial (33%). Most depressed patients are untreated, and half of antidepressant users remain depressed, suggesting that even when delivered, treatment is often inadequate or ineffective. (J Geriatr Psychiatry Neurol 2003; 16:178-183).

[1]  C. Mariani,et al.  Tolerability of paroxetine in Parkinson's disease: A prospective study , 2000, Movement disorders : official journal of the Movement Disorder Society.

[2]  I. Katz,et al.  Effect of Increasing the Dose and Duration of Sertraline Trial in the Treatment of Depressed Nursing Home Residents , 2003, Journal of geriatric psychiatry and neurology.

[3]  C. van Weel,et al.  Symptoms and duration of the prodromal phase in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[4]  R. Leiguarda,et al.  Cognitive functions in major depression and Parkinson disease. , 1997, Archives of neurology.

[5]  R. Chervin.  Epworth sleepiness scale? , 2003, Sleep medicine.

[6]  B. Pollock,et al.  Treatment-Resistant Depression in Late Life , 1998, Journal of geriatric psychiatry and neurology.

[7]  T. L. Brink,et al.  Clinical Gerontology: A Guide to Assessment and Intervention , 1986 .

[8]  L. Murri,et al.  Paroxetine in Parkinson’s disease: Effects on motor and depressive symptoms , 2000, Neurology.

[9]  R. Brown,et al.  Apathy in Parkinson’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[10]  R. Robinson,et al.  Specificity of affective and autonomic symptoms of depression in Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[11]  L. Kessing,et al.  Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. , 2001 .

[12]  L. Kessing,et al.  Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study , 2001, Acta psychiatrica Scandinavica.

[13]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[14]  Harold Alan Pincus,et al.  National trends in the outpatient treatment of depression. , 2002, JAMA.

[15]  Roger Kurlan,et al.  A survey of antidepressant drug use in Parkinson's disease , 1997, Neurology.

[16]  J. Cummings,et al.  The occurrence of depression in Parkinson's disease. A community-based study. , 1996, Archives of neurology.

[17]  H. Mayberg,et al.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[18]  W. Weiner,et al.  Non-recognition of depression and other non-motor symptoms in Parkinson's disease. , 2002, Parkinsonism & related disorders.

[19]  J. Turner.  Third Symposium on Parkinson's Disease , 1970 .

[20]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[21]  D. Deeg,et al.  Depression in Parkinson's disease. The impact of symptom overlap on prevalence. , 1998, Psychosomatics.

[22]  R. Schiffer,et al.  Anxiety and Parkinson's disease. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[23]  C. Katona,et al.  Screening, detection and management of depression in elderly primary care attenders. I: The acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. , 1994, Family practice.

[24]  H. C. D. de Vet,et al.  Treatment of depression in Parkinson's disease: a meta-analysis. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[25]  M. Johns,et al.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.

[26]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[27]  F. Verhey,et al.  The validity of the Hamilton and Montgomery‐Åsberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease , 2000, International journal of geriatric psychiatry.

[28]  K. Marder,et al.  An estimate of the incidence of depression in idiopathic Parkinson's disease. , 1992, Archives of neurology.

[29]  J. Marinus,et al.  The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson's disease: a discriminant analytic approach. , 2003, The Journal of neuropsychiatry and clinical neurosciences.

[30]  I. Katz,et al.  The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. , 2001, Postgraduate medicine.

[31]  W. Katon,et al.  Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. , 2000, JAMA.

[32]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[33]  R. Hauser,et al.  Sertraline for the treatment of depression in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[34]  J A Knottnerus,et al.  Increased risk of Parkinson’s disease after depression: A retrospective cohort study , 2002, Neurology.

[35]  Z. Schwab,et al.  Projection technique for evaluating surgery in Parkinson’s disease , 1969 .

[36]  P. Bech,et al.  Depression in idiopathic Parkinson's disease treated with citalopram: A placebo-controlled trial , 1998 .

[37]  G. Dell''Agnello,et al.  SSRIs Do Not Worsen Parkinson's Disease: Evidence from an Open-Label, Prospective Study , 2001, Clinical neuropharmacology.

[38]  D. Aarsland,et al.  Risk of dementia in Parkinson’s disease , 2001, Neurology.

[39]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[40]  M. Martens,et al.  Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[41]  S. Chiechio,et al.  The SSRI, Citalopram, Improves Bradykinesia in Patients With Parkinson's Disease Treated with L-Dopa , 2002, Clinical neuropharmacology.

[42]  Cheng‐Huai Lin,et al.  The correlation of depression with functional activity in Parkinson’s disease , 1997, Journal of Neurology.

[43]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[44]  P. Austin,et al.  Use of antidepressants among elderly subjects: trends and contributing factors. , 2000, The American journal of psychiatry.

[45]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[46]  R. J. Leo,et al.  Movement disorders associated with the serotonin selective reuptake inhibitors. , 1996, The Journal of clinical psychiatry.